(Q44507085)

English

A randomized, double-blinded, placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous transluminal coronary angioplasty: the ADMIRE (AmP579 Delivery fo

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 December 2017

A randomized, double-blinded, placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous transluminal coronary angioplasty: the ADMIRE (AmP579 Delivery fo (English)

1 reference

Europe PubMed Central

3 December 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Stephen L Kopecky

1

1 reference

Europe PubMed Central

3 December 2017

Ronnier J Aviles

2

1 reference

Europe PubMed Central

3 December 2017

Malcolm R Bell

3

1 reference

Europe PubMed Central

3 December 2017

Joseph K Lobl

4

1 reference

Europe PubMed Central

3 December 2017

Diane Tipping

5

1 reference

Europe PubMed Central

3 December 2017

Gregg Frommell

6

1 reference

Europe PubMed Central

3 December 2017

Karen Ramsey

7

1 reference

Europe PubMed Central

3 December 2017

Anne E Holland

8

1 reference

Europe PubMed Central

3 December 2017

Mark Midei

9

1 reference

Europe PubMed Central

3 December 2017

Abnash Jain

10

1 reference

Europe PubMed Central

3 December 2017

Mirle Kellett

11

1 reference

Europe PubMed Central

3 December 2017

Raymond J Gibbons

12

1 reference

Europe PubMed Central

3 December 2017

AmP579 Delivery for Myocardial Infarction REduction study

13

1 reference

Europe PubMed Central

3 December 2017

language of work or name

0 references

publication date

1 July 2003

1 reference

Europe PubMed Central

3 December 2017

American Heart Journal

1 reference

Europe PubMed Central

3 December 2017

146

1 reference

Europe PubMed Central

3 December 2017

146-152

1 reference

Europe PubMed Central

3 December 2017

1

1 reference

Europe PubMed Central

3 December 2017

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900172-8

7 January 2021

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900172-8

7 January 2021

Coronary cyclic flow variations "precondition" ischemic myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900172-8

7 January 2021

Long-term outcome of patients with depressed left ventricular function undergoing percutaneous transluminal coronary angioplasty. The NHLBI PTCA Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900172-8

7 January 2021

Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900172-8

7 January 2021

Intracoronary adenosine administered after reperfusion limits vascular injury after prolonged ischemia in the canine model.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900172-8

7 January 2021

Adenosine: a physiological modulator of superoxide anion generation by human neutrophils.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900172-8

7 January 2021

A novel adenosine analog, AMP579, inhibits neutrophil activation, adherence and neutrophil-mediated injury to coronary vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900172-8

7 January 2021

Cardiovascular pharmacology of the adenosine A1/A2-receptor agonist AMP 579: coronary hemodynamic and cardioprotective effects in the canine myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900172-8

7 January 2021

Comparative study of AMP579 and adenosine in inhibition of neutrophil-mediated vascular and myocardial injury during 24 h of reperfusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900172-8

7 January 2021

Limitation of infarct size in rabbit hearts by the novel adenosine receptor agonist AMP 579 administered at reperfusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900172-8

7 January 2021

Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900172-8

7 January 2021

International diagnostic criteria for acute myocardial infarction and acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900172-8

7 January 2021

Myocardial ischaemia during daily life in patients with stable angina: its relation to symptoms and heart rate changes.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900172-8

7 January 2021

Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900172-8

7 January 2021

Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900172-8

7 January 2021

Effects of the presence or absence of preceding angina pectoris on left ventricular function after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900172-8

7 January 2021

Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900172-8

7 January 2021

Mechanisms of cardiac pain during coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900172-8

7 January 2021

Prodromal angina limits infarct size. A role for ischemic preconditioning.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900172-8

7 January 2021

Continuous 12-lead ST-segment recovery analysis in the TAMI 7 study. Performance of a noninvasive method for real-time detection of failed myocardial reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900172-8

7 January 2021

The "no-reflow" phenomenon after temporary coronary occlusion in the dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900172-8

7 January 2021

Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900172-8

7 January 2021

Assessment of "microvascular no-reflow phenomenon" using technetium-99m macroaggregated albumin scintigraphy in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900172-8

7 January 2021

Adenosine for myocardial protection in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900172-8

7 January 2021

Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900172-8

7 January 2021

Intravenous adenosine and lidocaine in patients with acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900172-8

7 January 2021

Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900172-8

7 January 2021

Preconditioning of human myocardium with adenosine during coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900172-8

7 January 2021

Identifiers

10.1016/S0002-8703(03)00172-8

1 reference

Europe PubMed Central

3 December 2017

1 reference

Europe PubMed Central

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44507085&oldid=1371306488"